Literature DB >> 8305169

Effect of long-term administration of 1,25 (OH)2 vitamin D3 on blood pressure and resistance artery contractility in the spontaneously hypertensive rat.

R D Bukoski1, J Li, J Bo.   

Abstract

The effect of long-term daily injection of 1,25 (OH)2 vitamin D3 on blood pressure and contractile force generation by subsequently isolated mesenteric resistance arteries was examined using the spontaneously hypertensive rat (SHR) model of genetic hypertension. Beginning at 6 weeks of age, male SHR were given daily intraperitoneal injections of vehicle, or 1,25 (OH)2 vitamin D3 at 20, 30, or 40 ng/100 g body weight. Body weight and systolic blood pressure were determined weekly. After 9 weeks, serum was prepared for electrolyte analysis and mesenteric resistance arteries were isolated for assessment of contractile function using a wire myograph. Blood pressure became elevated in the rats receiving 20 and 40 ng 1,25 (OH)2 vitamin D3 after 5 weeks and remained elevated in the 40 ng group during the sixth week. Between weeks six to nine, blood pressure continued to rise but was not different among the groups. In addition, during the period between 6 and 9 weeks, there was a decline in the rate of weight gain in rats receiving 30 and 40 ng 1,25 (OH)2 vitamin D3. Serum ionized Ca2+ was significantly elevated in the three groups treated with 1,25 (OH)2 vitamin D3 compared with control. The active stress response of resistance arteries to norepinephrine and arginine vasopressin was significantly elevated in rats that received 30 and 40 ng 1,25 (OH)2 vitamin D3, but no differences in apparent sensitivity to these agonists were detected.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8305169     DOI: 10.1093/ajh/6.11.944

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  4 in total

1.  Recovery of impaired K+ channels in mesenteric arteries from spontaneously hypertensive rats by prolonged treatment with cholecalciferol.

Authors:  A C Borges; T Feres; L M Vianna; T B Paiva
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

2.  Vitamin D receptor-modulated Hsp70/AT1 expression may protect the kidneys of SHRs at the structural and functional levels.

Authors:  Isabel Mercedes García; Liliana Altamirano; Luciana Mazzei; Miguel Fornés; Fernando Darío Cuello-Carrión; León Ferder; Walter Manucha
Journal:  Cell Stress Chaperones       Date:  2013-11-13       Impact factor: 3.667

3.  Vitamin D induces increased systolic arterial pressure via vascular reactivity and mechanical properties.

Authors:  Priscila Portugal Dos Santos; Bruna Paola Murino Rafacho; Andréa de Freitas Gonçalves; Rodrigo Gibin Jaldin; Thiago Bruder do Nascimento; Marcondes Alves Barbosa Silva; Stêfany Bruno Assis Cau; Meliza Goi Roscani; Paula Schimdt Azevedo; Marcos Ferreira Minicucci; Rita de Cássia Tostes; Leonardo Antonio Memede Zornoff; Sergio Alberto Rupp de Paiva
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

4.  Modulation of the sympathetic nervous system in youngsters by vitamin-D supplementation.

Authors:  Rune Tønnesen; Peter Schwarz; Peter Hovind; Lars Thorbjørn Jensen
Journal:  Physiol Rep       Date:  2018-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.